Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
RBKB vs FXNC vs CZWI vs MNSB vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
RBKB vs FXNC vs CZWI vs MNSB vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $186M | $273M | $207M | $184M | $896.00B |
| Revenue (TTM) | $76M | $115M | $90M | $135M | $280.33B |
| Net Income (TTM) | $10M | $18M | $14M | $16M | $57.05B |
| Gross Margin | 68.2% | 74.7% | 54.7% | 54.3% | 60.0% |
| Operating Margin | 16.7% | 19.0% | 7.0% | 14.1% | 25.9% |
| Forward P/E | 18.2x | 12.8x | 11.8x | 11.0x | 14.4x |
| Total Debt | $30M | $43M | $52M | $70M | $942.38B |
| Cash & Equiv. | $17M | $161M | $119M | $26M | $343.34B |
RBKB vs FXNC vs CZWI vs MNSB vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Rhinebeck Bancorp, … (RBKB) | 100 | 254.7 | +154.7% |
| First National Corp… (FXNC) | 100 | 217.5 | +117.5% |
| Citizens Community … (CZWI) | 100 | 312.8 | +212.8% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RBKB vs FXNC vs CZWI vs MNSB vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RBKB has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 39.8%, EPS growth 215.0%
- Lower volatility, beta 0.29, Low D/E 22.1%, current ratio 493.23x
- 39.8% NII/revenue growth vs CZWI's -9.4%
- Beta 0.29 vs JPM's 0.94, lower leverage
FXNC is the #2 pick in this set and the best alternative if income & stability and bank quality is your priority.
- Dividend streak 11 yrs, beta 0.52, yield 2.0%
- NIM 3.6% vs JPM's 2.2%
- 2.0% yield, 11-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend)
- +57.8% vs JPM's +21.8%
CZWI is the clearest fit if your priority is defensive.
- Beta 0.50, yield 1.7%, current ratio 3015.31x
MNSB is the clearest fit if your priority is value.
- Lower P/E (11.0x vs 11.8x)
JPM ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs FXNC's 258.5%
- PEG 0.81 vs FXNC's 8.59
- Efficiency ratio 0.3% vs FXNC's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs FXNC's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 39.8% NII/revenue growth vs CZWI's -9.4% | |
| Value | Lower P/E (11.0x vs 11.8x) | |
| Quality / Margins | Efficiency ratio 0.3% vs FXNC's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.29 vs JPM's 0.94, lower leverage | |
| Dividends | 2.0% yield, 11-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +57.8% vs JPM's +21.8% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs FXNC's 0.5% |
RBKB vs FXNC vs CZWI vs MNSB vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RBKB vs FXNC vs CZWI vs MNSB vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
MNSB leads 1 • FXNC leads 1 • RBKB leads 0 • CZWI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3696.1x RBKB's $76M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $76M | $115M | $90M | $135M | $280.3B |
| EBITDAEarnings before interest/tax | $14M | $25M | $9M | $23M | $81.4B |
| Net IncomeAfter-tax profit | $10M | $18M | $14M | $16M | $57.0B |
| Free Cash FlowCash after capex | $11M | $21M | $11M | $11M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +68.2% | +74.7% | +54.7% | +54.3% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +16.7% | +19.0% | +7.0% | +14.1% | +25.9% |
| Net MarginNet income ÷ Revenue | +13.2% | +15.4% | +16.0% | +11.5% | +20.4% |
| FCF MarginFCF ÷ Revenue | +14.9% | +18.2% | +12.4% | +7.9% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +184.0% | +7.1% | +63.0% | +120.9% | +16.0% |
Valuation Metrics
MNSB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.2x trailing earnings, MNSB trades at a 22% valuation discount to RBKB's 18.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs FXNC's 10.32x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $186M | $273M | $207M | $184M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $200M | $155M | $140M | $227M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 18.16x | 15.40x | 14.70x | 14.16x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.82x | 11.79x | 11.03x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 1.68x | 10.32x | 2.90x | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 14.70x | 7.05x | 15.69x | 11.90x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.45x | 2.43x | 2.29x | 1.35x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.34x | 1.46x | 1.11x | 0.87x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 17.09x | 12.99x | 19.90x | 17.26x | 8.88x |
Profitability & Efficiency
FXNC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for MNSB. RBKB carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), RBKB scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.7% | +10.0% | +7.8% | +7.3% | +15.9% |
| ROA (TTM)Return on assets | +0.8% | +0.9% | +0.8% | +0.7% | +1.3% |
| ROICReturn on invested capital | +5.2% | +7.7% | +2.0% | +5.0% | +4.5% |
| ROCEReturn on capital employed | +1.7% | +9.9% | +0.6% | +6.0% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.22x | 0.23x | 0.28x | 0.32x | 2.60x |
| Net DebtTotal debt minus cash | $13M | -$118M | -$67M | $43M | $599.0B |
| Cash & Equiv.Liquid assets | $17M | $161M | $119M | $26M | $343.3B |
| Total DebtShort + long-term debt | $30M | $43M | $52M | $70M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.56x | 0.84x | 0.16x | 0.31x | 0.74x |
Total Returns (Dividends Reinvested)
Evenly matched — CZWI and JPM each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,813 for MNSB. Over the past 12 months, FXNC leads with a +57.8% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors CZWI at 36.4% vs MNSB's 4.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +39.5% | +24.4% | +24.3% | +26.5% | -0.5% |
| 1-Year ReturnPast 12 months | +34.8% | +57.8% | +52.1% | +37.2% | +21.8% |
| 3-Year ReturnCumulative with dividends | +151.9% | +103.7% | +153.7% | +13.1% | +138.2% |
| 5-Year ReturnCumulative with dividends | +55.7% | +71.0% | +69.0% | +18.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | +42.2% | +258.5% | +149.0% | +135.4% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +36.1% | +26.8% | +36.4% | +4.2% | +33.6% |
Risk & Volatility
Evenly matched — RBKB and MNSB each lead in 1 of 2 comparable metrics.
Risk & Volatility
RBKB is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MNSB currently trades 99.0% from its 52-week high vs RBKB's 92.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.29x | 0.52x | 0.50x | 0.60x | 0.94x |
| 52-Week HighHighest price in past year | $17.99 | $30.51 | $22.62 | $25.17 | $337.25 |
| 52-Week LowLowest price in past year | $9.41 | $18.31 | $12.83 | $17.86 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +92.9% | +99.0% | +94.9% | +99.0% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 63.2 | 67.0 | 51.2 | 65.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 11K | 79K | 41K | 45K | 7.0M |
Analyst Outlook
Evenly matched — FXNC and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FXNC as "Buy", CZWI as "Buy", MNSB as "Hold", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -30.4% for FXNC (target: $21). For income investors, FXNC offers the higher dividend yield at 2.03% vs MNSB's 1.60%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $21.00 | — | — | $339.75 |
| # AnalystsCovering analysts | — | 1 | 2 | 1 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +1.7% | +1.6% | +1.9% |
| Dividend StreakConsecutive years of raises | — | 11 | 6 | 0 | 15 |
| Dividend / ShareAnnual DPS | — | $0.61 | $0.37 | $0.40 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +0.1% | +3.0% | +2.4% | +3.9% |
JPM leads in 1 of 6 categories (Income & Cash Flow). MNSB leads in 1 (Valuation Metrics). 3 tied.
RBKB vs FXNC vs CZWI vs MNSB vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RBKB or FXNC or CZWI or MNSB or JPM a better buy right now?
For growth investors, Rhinebeck Bancorp, Inc.
(RBKB) is the stronger pick with 39. 8% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). MainStreet Bancshares, Inc. (MNSB) offers the better valuation at 14. 2x trailing P/E (11. 0x forward), making it the more compelling value choice. Analysts rate First National Corporation (FXNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RBKB or FXNC or CZWI or MNSB or JPM?
On trailing P/E, MainStreet Bancshares, Inc.
(MNSB) is the cheapest at 14. 2x versus Rhinebeck Bancorp, Inc. at 18. 2x. On forward P/E, MainStreet Bancshares, Inc. is actually cheaper at 11. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus First National Corporation's 8. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RBKB or FXNC or CZWI or MNSB or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +18. 1% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus RBKB's +42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RBKB or FXNC or CZWI or MNSB or JPM?
By beta (market sensitivity over 5 years), Rhinebeck Bancorp, Inc.
(RBKB) is the lower-risk stock at 0. 29β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 224% more volatile than RBKB relative to the S&P 500. On balance sheet safety, Rhinebeck Bancorp, Inc. (RBKB) carries a lower debt/equity ratio of 22% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — RBKB or FXNC or CZWI or MNSB or JPM?
By revenue growth (latest reported year), Rhinebeck Bancorp, Inc.
(RBKB) is pulling ahead at 39. 8% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: Rhinebeck Bancorp, Inc. grew EPS 215. 0% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RBKB or FXNC or CZWI or MNSB or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RBKB or FXNC or CZWI or MNSB or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus First National Corporation's 8. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, MainStreet Bancshares, Inc. (MNSB) trades at 11. 0x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 3. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — RBKB or FXNC or CZWI or MNSB or JPM?
In this comparison, FXNC (2.
0% yield), JPM (1. 9% yield), CZWI (1. 7% yield), MNSB (1. 6% yield) pay a dividend. RBKB does not pay a meaningful dividend and should not be held primarily for income.
09Is RBKB or FXNC or CZWI or MNSB or JPM better for a retirement portfolio?
For long-horizon retirement investors, First National Corporation (FXNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), 2. 0% yield, +258. 5% 10Y return). Both have compounded well over 10 years (FXNC: +258. 5%, RBKB: +42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RBKB and FXNC and CZWI and MNSB and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: RBKB is a small-cap high-growth stock; FXNC is a small-cap high-growth stock; CZWI is a small-cap deep-value stock; MNSB is a small-cap deep-value stock; JPM is a large-cap deep-value stock. FXNC, CZWI, MNSB, JPM pay a dividend while RBKB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.